Hematology

We explore the latest advancements in gene therapy for the treatment of haemophilia, including what the future of gene therapy could mean for clinicians…

In this episode, we have two experts in the field of direct oral anticoagulants for the treatment of cancer related venous thromboembolisms.

In this podcast, Dr. Subarna Chakravorty and Dr. Rachel Kesse-Adu discuss their highlights from ASH surrounding sickle cell disease.

Richard Cowan, oncologist and expert on cutaneous T-cell lymphomas, provides insights into both mycosis fungoides and sézary syndrome.

In this episode, we discuss the treatment of patients who have acute myeloid leukemia (AML) as well as FMS-like tyrosine kinase 3 gene (FLT3) mutations.

This episode includes a discussion around myelodysplastic syndrome (MDS). The expert speakers elucidate on data regarding immunotherapy for the treatment of patients living with MDS from the recent European School of Haematology 7th Translational Research Conference.

We discuss developments and data presented at the ASH 2020 virtual conference regarding the management of patients with acute myeloid leukaemia (AML).

This episode, sponsored by Vifor pharma, provides an overview of the current challenges in achieving remission for patients with ANCA-associated vasculitis.